中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 42 Issue 8
Aug.  2026
Turn off MathJax
Article Contents

Primary periampullary squamous cell carcinoma: A case report

DOI: 10.12449/JCH260827
Research funding:

Baoding Science and Technology Bureau Special Project for Improving Innovation Capability (2494F019)

More Information
  • Corresponding author: Yang Jihong, liujw99108@163.com (ORCID: 0009-0002-0189-3042)
  • Received Date: 2025-11-11
  • Accepted Date: 2026-01-14
  • Published Date: 2026-08-25
  • Periampullary carcinoma is a malignant tumor of the biliopancreatic system originating from the ampulla of Vater, with the main pathological subtypes of intestinal-type and pancreatobiliary-type adenocarcinoma. Primary periampullary squamous cell carcinoma is relatively rare in clinical practice, with great difficulties in preoperative diagnosis and a lack of clinical experience and standardized diagnosis and treatment regimens. This article reports a case of primary periampullary squamous cell carcinoma in a male patient aged 55 years. The patient was admitted due to cutaneous and scleral jaundice for 2 weeks. Laboratory examination revealed obstructive jaundice, impaired liver function, and an increase in carbohydrate antigen 19-9, and radiological examination showed obstruction of the distal common bile duct and a space-occupying lesion in the ampullary region, leading to a preliminary clinical diagnosis of periampullary carcinoma of Vater. After admission, endoscopic retrograde cholangiopancreatography was first performed to relieve obstructive jaundice, and then biopsy of the ampullary lesion was conducted, with pathological findings highly suspicious for malignancy. Radical pancreaticoduodenectomy was performed after improvement in liver function, and postoperative pathology confirmed the diagnosis of moderately differentiated squamous cell carcinoma of the ampulla. PET-CT reexamination on day 52 after surgery showed well-healed surgical anastomosis and multiple hypermetabolic nodules in the right hepatic lobe, which could not rule out tumor metastasis. This case report can provide a reference for improving awareness of this rare disease and optimizing related diagnosis and treatment decisions in clinical practice.

     

  • loading
  • [1]
    Zimmermann C, Wolk S, Aust D E, et al. The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma[J]. Sci Rep, 2019, 9( 1): 12676. DOI: 10.1038/s41598-019-49179-w.
    [2]
    Liu Fangfang, Shen Danhua, Wang Hanlin, et al. Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance[J]. Chin J Pathol, 2019, 48( 2): 92- 97. DOI: 10.3760/cma.j.issn.0529-5807.2019.02.003.

    刘芳芳, 沈丹华, 王汉林, 等. 联合应用蛋白标志物鉴定壶腹癌病理亚型及其临床意义[J]. 中华病理学杂志, 2019, 48( 2): 92- 97. DOI: 10.3760/cma.j.issn.0529-5807.2019.02.003.
    [3]
    Westgaard A, Pomianowska E, Clausen O P F, et al. Intestinal-type and pancreatobiliary-type adenocarcinomas: How does ampullary carcinoma differ from other periampullary malignancies?[J]. Ann Surg Oncol, 2013, 20( 2): 430- 439. DOI: 10.1245/s10434-012-2603-0.
    [4]
    Hui Y F, Ke F, Lu W, et al. Primary squamous cell carcinoma of the duodenum: A case report and literature review[J]. Chemotherapy, 2025, 70( 2): 102- 108. DOI: 10.1159/000542485.
    [5]
    Hu J B, Zhu Y H, Jin M, et al. Gastric and duodenal squamous cell carcinoma: Metastatic or primary?[J]. World J Surg Oncol, 2013, 11( 1): 204. DOI: 10.1186/1477-7819-11-204.
    [6]
    Chen Wenju, Luo Huiqin, Wu Shusheng, et al. Analysis of influencing factors of tumor recurrence in patients with periampullary carcinoma after radical resection[J]. Clin J Med Offic, 2024, 52( 12): 1231- 1234. DOI: 10.16680/j.1671-3826.2024.12.06.

    陈文菊, 罗会芹, 吴书胜, 等. 壶腹周围癌患者根治性切除术后肿瘤复发影响因素分析[J]. 临床军医杂志, 2024, 52( 12): 1231- 1234. DOI: 10.16680/j.1671-3826.2024.12.06.
    [7]
    Neoptolemos J P, Moore M J, Cox T F, et al. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: The ESPAC-3 periampullary cancer randomized trial[J]. JAMA, 2012, 308( 2): 147- 156. DOI: 10.1001/jama.2012.7352.
    [8]
    Mori S, Aoki T, Shiraki T, et al. Efficacy and feasibility of adjuvant gemcitabine plus cisplatin chemotherapy after major hepatectomy for biliary tract cancer[J]. Anticancer Res, 2021, 41( 10): 5231- 5240. DOI: 10.21873/anticanres.15342.
    [9]
    Hakoda H, Kawaguchi Y, Miyata Y, et al. Advanced adenosquamous carcinoma of the ampulla of vater treated with adjuvant chemotherapy after pancreaticoduodenectomy[J]. Case Rep Gastroenterol, 2024, 18( 1): 129- 135. DOI: 10.1159/000537900.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Article Metrics

    Article views (11) PDF downloads(0) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return